Heartwood Wealth Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
CIM
AC
MPWT
NAM
CNB
LTAS
Heartwood Wealth Advisors's RMD Position: Q2 2026 in Review
Heartwood Wealth Advisors reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $119K and leaving 1,750 shares worth $341K. The position accounts for 0.03% of the portfolio, ranked #175.
Heartwood Wealth Advisors first reported a position in RMD in Q1 2022 and has held it in 15 quarters since. The position peaked at $636K in Q3 2025. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Heartwood Wealth Advisors held 1,750 shares of ResMed worth $341K as of Q2 2026.
- Heartwood Wealth Advisors sold 573 ResMed shares in Q2 2026, an estimated $119K.
- ResMed made up 0.03% of Heartwood Wealth Advisors's portfolio in Q2 2026, its #175 holding.
- Heartwood Wealth Advisors first reported a position in ResMed in Q1 2022 and has held it in 15 quarters since.
- Heartwood Wealth Advisors's ResMed position peaked at $636K in Q3 2025.
- 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Heartwood Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.